Despite facing a dip in loan performance and market share, Credit Acceptance Corp (CACC) posted growth in adjusted earnings per share for Q4 2025, highlighting strategic investments in dealer technology and a disciplined, long-term financial approach.
While flashy, unprofitable tech stocks often dominate headlines, German thermal management specialist technotrans demonstrates that disciplined earnings growth and reasonable executive compensation can build a more sustainable investment case, as its EPS and margins climb.
Mastercard reported robust Q4 and full-year 2025 results, driven by double-digit revenue growth and surging value-added services. Executives expressed confidence for 2026, highlighting strategic wins, investments in digital assets like stablecoins, and a focus on 'agentic commerce,' even as they plan a restructuring affecting 4% of staff.
Sea Limited's latest earnings reveal a strategic pivot back to aggressive investment in its e-commerce arm, Shopee, driving robust revenue growth but squeezing near-term margins. This move reignites the debate on whether the Southeast Asian tech giant can sustainably balance expansion with profitability.
Colony Bankcorp (CBAN) reported improved operating performance in Q4 2025, with executives detailing on-track integration of TC Federal and momentum in fee-based businesses. The bank targets a 1.20% return on assets for 2026 and signals appetite for further acquisitions.
The technology-focused lender reported solid 2025 earnings, highlighted accelerating deposit inflows and a strategic shift away from its legacy SBA portfolio. Management forecasts continued growth for 2026, banking on its digital offerings and a key securitization success.
Chip designer MaxLinear capped off a transformative 2025 with a strong fourth quarter, reporting 30% full-year revenue growth and positive cash flow ahead of schedule. CEO Kishore Seendripu pointed to surging demand in data center optical interconnects and wireless infrastructure as key catalysts, positioning the company for even faster growth in 2026.
Despite a stellar share price run, MasTec's earnings quality is under scrutiny as persistent margin pressures from supply chain strains and strategic growth investments challenge its financial resilience. Investors are watching to see if management can steer the infrastructure giant toward more sustainable profitability.
Insulet Corporation (NASDAQ: PODD), the maker of the tubeless Omnipod insulin delivery system, is drawing investor attention with a potent mix of surging cash flow, market expansion, and a recurring revenue model. As the company capitalizes on recent regulatory wins and international growth, we examine the bull case and the risks ahead.
Coca-Cola FEMSA (KOF), the world's largest Coca-Cola bottler, presents a compelling investment case. Despite facing currency headwinds, its dominant position in high-growth Latin American markets, fortress balance sheet, and strategic digital investments suggest significant upside potential for patient investors.
Amidst a mixed Asian market landscape, companies with significant insider ownership are drawing investor attention. We examine three high-growth firms from South Korea and China where executives and directors have substantial skin in the game.
Business Insider prepares to release its annual list spotlighting venture capital's most promising young talent. Join a live session with the journalists behind the report and one of the honored investors for insights into career paths and emerging opportunities.
As growth investing maintains its momentum, fueled by economic expansion and AI investment, we analyze three standout ETFs that offer investors diversified, cost-effective exposure to this high-performing segment.
Canopy Growth's shares have plummeted over 99% in five years, yet analysts warn its challenges run deeper than its stock price suggests. Despite recent U.S. regulatory changes, structural industry headwinds and the company's own track record make it a speculative play at best.
As investors navigate a complex economic landscape, companies with significant insider ownership and robust earnings forecasts are drawing attention. We examine three ASX-listed firms where leadership's skin in the game aligns with ambitious growth projections.
IDEXX Laboratories (IDXX) reported robust double-digit growth for Q4 2025, driven by record placements of its premium diagnostic instruments and expanding test utilization. While acknowledging persistent softness in U.S. veterinary visit volumes, the company outlined a confident initial 2026 forecast, banking on its innovation pipeline and the transformative impact of its inVue Dx system.
Wealthtech giant Envestnet unveils a new executive structure, appointing Jonathan Linstra to spearhead growth initiatives alongside relationship management, backed by a $1 billion product investment plan.
Specialty insurer Kinsale Capital Group continues to outpace broader industry growth in key metrics, driven by its focus on underserved, higher-risk markets. However, its premium valuation and recent stock volatility have intensified debate among investors about its long-term sustainability.
The International Monetary Fund projects average growth in sub-Saharan Africa at 4.6% for the year, edging ahead of Asia's 4.1%, signaling a potential turning point driven by demographics but tempered by significant investment challenges.
Despite a recent 4.7% stock decline, Edwards Lifesciences (NYSE: EW) boasts a robust 13% Return on Equity, outperforming its industry. Yet, its modest 4.6% five-year growth rate raises questions about future potential and market valuation.
